Lymph Node Dissection for Differentiated Thyroid Cancer

  • Jeff Moley


Lymph node dissection is commonly required as either initial or salvage treatment of differentiated thyroid cancer. This chapter reviews the lymphatic anatomy of the neck and the frequency of nodal involvement in differentiated thyroid cancer and reviews the indications for lymphadenectomy, including the controversial utility of prophylactic nodal dissections. The chapter provides extensive details regarding the technical aspects of both central and lateral compartment lymph node dissections.


Lymph node dissection Lymphadenectomy Neck dissection Central neck dissection Lateral neck dissection Modified radical neck dissection Lymph node anatomy Lymph node levels Central compartment Lateral compartment Technique Complications Indications for lymphadenectomy Hypoparathyroidism Recurrent laryngeal nerve injury 


  1. 1.
    Morris LG, Sikora AG, Tosteson TD, Davies L. The increasing incidence of thyroid cancer: the influence of access to care. Thyroid. 2013;23(7):885–91.CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin. 2013;63(1):11–30.CrossRefPubMedGoogle Scholar
  3. 3.
    Kweon SS, Shin MH, Chung IJ, Kim YJ, Choi JS. Thyroid cancer is the most common cancer in women, based on the data from population-based cancer registries, South Korea. Jpn J Clin Oncol. 2013;43(10):1039–46.CrossRefPubMedGoogle Scholar
  4. 4.
    Bilimoria KY, Bentrem DJ, Ko CY, Stewart AK, Winchester DP, Talamonti MS, Sturgeon C. Extent of surgery affects survival for papillary thyroid cancer. Ann Surg. 2007;246(3):375–81. Discussion 381–374CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Moley JF, DeBenedetti MK. Patterns of nodal metastases in palpable medullary thyroid carcinoma: recommendations for extent of node dissection. Ann Surg. 1999;229(6):880–7. Discussion 887–888CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Sadowski BM, Snyder SK, Lairmore TC. Routine bilateral central lymph node clearance for papillary thyroid cancer. Surgery. 2009;146(4):696–703. Discussion 703–695CrossRefPubMedGoogle Scholar
  7. 7.
    Tuttle RM, Ball DW, Byrd D, Dilawari RA, Doherty GM, Duh QY, Ehya H, Farrar WB, Haddad RI, Kandeel F, Kloos RT, Kopp P, Lamonica DM, Loree TR, Lydiatt WM, McCaffrey JC, Olson Jr JA, Parks L, Ridge JA, Shah JP, Sherman SI, Sturgeon C, Waguespack SG, Wang TN, Wirth LJ, National Comprehensive Cancer Network. Thyroid carcinoma. J Natl Compr Cancer Netw. 2010;8(11):1228–74.CrossRefGoogle Scholar
  8. 8.
    Creach KM, Gillanders WE, Siegel BA, Haughey BH, Moley JF, Grigsby PW. Management of cervical nodal metastasis detected on I-131 scintigraphy after initial surgery of well-differentiated thyroid carcinoma. Surgery. 2010;148(6):1198–204. Discussion 1204–1196CrossRefPubMedGoogle Scholar
  9. 9.
    Frazell EL, Foote Jr FW. Papillary cancer of the thyroid; a review of 25 years of experience. Cancer. 1958;11(5):895–922.CrossRefPubMedGoogle Scholar
  10. 10.
    Ito Y, Higashiyama T, Takamura Y, Miya A, Kobayashi K, Matsuzuka F, Kuma K, Miyauchi A. Risk factors for recurrence to the lymph node in papillary thyroid carcinoma patients without preoperatively detectable lateral node metastasis: validity of prophylactic modified radical neck dissection. World J Surg. 2007;31(11):2085–91.CrossRefPubMedGoogle Scholar
  11. 11.
    Reddy RM, Grigsby PW, Moley JF, Hall BL. Lymph node metastases in differentiated thyroid cancer under 2 cm. Surgery. 2006;140(6):1050–4. Discussion 1054–1055CrossRefPubMedGoogle Scholar
  12. 12.
    American Thyroid Association Surgery Working Group, American Association of Endocrine Surgeons, American Academy of Otolaryngology-Head and Neck Surgery, American Head and Neck Society, Carty SE, Cooper DS, Doherty GM, Duh QY, Kloos RT, Mandel SJ, Randolph GW, Stack Jr BC, Steward DL, Terris DJ, Thompson GB, Tufano RP, Tuttle RM, Udelsman R. Consensus statement on the terminology and classification of central neck dissection for thyroid cancer. Thyroid. 2009;19(11):​1153–8.CrossRefGoogle Scholar
  13. 13.
    Cody III HS, Shah JP. Locally invasive, well-differentiated thyroid cancer. 22 years’ experience at Memorial Sloan-Kettering Cancer Center. Am J Surg. 1981;142(4):480–3.CrossRefPubMedGoogle Scholar
  14. 14.
    Mizuno S, Funahashi H, Sugiura H, Imai T, Takeuchi M, Sato Y, Takagi H. [Study on extensive lymph node dissection: metastatic lymph nodes in papillary carcinoma of the thyroid]. Nihon Geka Gakkai Zasshi. 1986;87(8): 883–8.Google Scholar
  15. 15.
    Sugino K, Kure Y, Iwasaki H, Ozaki O, Mimura T, Matsumoto A, Ito K. Metastases to the regional lymph nodes, lymph node recurrence, and distant metastases in nonadvanced papillary thyroid carcinoma. Surg Today. 1995;25(4):324–8.CrossRefPubMedGoogle Scholar
  16. 16.
    Tisell LE. Role of lymphadenectomy in the treatment of differentiated thyroid carcinomas. Br J Surg. 1998;85(8):1025–6.CrossRefPubMedGoogle Scholar
  17. 17.
    Machens A, Hauptmann S, Dralle H. Prediction of lateral lymph node metastases in medullary thyroid cancer. Br J Surg. 2008;95(5):586–91.CrossRefPubMedGoogle Scholar
  18. 18.
    Machens A, Holzhausen HJ, Dralle H. Skip metastases in thyroid cancer leaping the central lymph node compartment. Arch Surg. 2004;139(1):43–5.CrossRefPubMedGoogle Scholar
  19. 19.
    Woolner LB, Beahrs OH, Black BM, Mc CW, Keating Jr FR. Classification and prognosis of thyroid carcinoma. A study of 885 cases observed in a thirty year period. Am J Surg. 1961;102:354–87.CrossRefPubMedGoogle Scholar
  20. 20.
    Mazzaferri EL, Young RL, Oertel JE, Kemmerer WT, Page CP. Papillary thyroid carcinoma: the impact of therapy in 576 patients. Medicine (Baltimore). 1977;56(3):171–96.CrossRefGoogle Scholar
  21. 21.
    Samaan NA, Maheshwari YK, Nader S, Hill Jr CS, Schultz PN, Haynie TP, Hickey RC, Clark RL, Goepfert H, Ibanez ML, Litton CE. Impact of therapy for differentiated carcinoma of the thyroid: an analysis of 706 cases. J Clin Endocrinol Metab. 1983;56(6):1131–8.CrossRefPubMedGoogle Scholar
  22. 22.
    McHenry C, Jarosz H, Lawrence AM, Paloyan E. Improving postoperative recurrence rates for carcinoma of the thyroid gland. Surg Gynecol Obstet. 1989;169(5):429–34.PubMedGoogle Scholar
  23. 23.
    Tisell LE, Nilsson B, Molne J, Hansson G, Fjalling M, Jansson S, Wingren U. Improved survival of patients with papillary thyroid cancer after surgical microdissection. World J Surg. 1996;20(7):854–9.CrossRefPubMedGoogle Scholar
  24. 24.
    Scheumann GF, Gimm O, Wegener G, Hundeshagen H, Dralle H. Prognostic significance and surgical management of locoregional lymph node metastases in papillary thyroid cancer. World J Surg. 1994;18(4):559–67. Discussion 567–558CrossRefPubMedGoogle Scholar
  25. 25.
    Chen H, Udelsman R. Papillary thyroid carcinoma: justification for total thyroidectomy and management of lymph node metastases. Surg Oncol Clin N Am. 1998;7(4):645–63.PubMedGoogle Scholar
  26. 26.
    Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, Mandel SJ, Mazzaferri EL, McIver B, Pacini F, Schlumberger M, Sherman SI, Steward DL, Tuttle RM. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid. 2009;19(11):​1167–214.CrossRefPubMedGoogle Scholar
  27. 27.
    NCCN. Thyroid carcinoma (version 2.2012). NCCN clinical practice guidelines in oncology; 2012.Google Scholar
  28. 28.
    Barczynski M, Konturek A, Stopa M, Nowak W. Prophylactic central neck dissection for papillary thyroid cancer. Br J Surg. 2013;100(3):410–8.CrossRefPubMedGoogle Scholar
  29. 29.
    Hughes CJ, Shaha AR, Shah JP, Loree TR. Impact of lymph node metastasis in differentiated carcinoma of the thyroid: a matched-pair analysis. Head Neck. 1996;18(2):127–32.CrossRefPubMedGoogle Scholar
  30. 30.
    Mazzaferri EL, Jhiang SM. Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med. 1994;97(5):​418–28.CrossRefPubMedGoogle Scholar
  31. 31.
    Hughes DT, White ML, Miller BS, Gauger PG, Burney RE, Doherty GM. Influence of prophylactic central lymph node dissection on postoperative thyroglobulin levels and radioiodine treatment in papillary thyroid cancer. Surgery. 2010;148(6):1100–6. Discussion 1006–1107CrossRefPubMedGoogle Scholar
  32. 32.
    Shan CX, Zhang W, Jiang DZ, Zheng XM, Liu S, Qiu M. Routine central neck dissection in differentiated thyroid carcinoma: a systematic review and meta-analysis. Laryngoscope. 2012;122(4):797–804.CrossRefPubMedGoogle Scholar
  33. 33.
    Zetoune T, Keutgen X, Buitrago D, Aldailami H, Shao H, Mazumdar M, Fahey 3rd TJ, Zarnegar R. Prophylactic central neck dissection and local recurrence in papillary thyroid cancer: a meta-analysis. Ann Surg Oncol. 2010;17(12):3287–93.CrossRefPubMedGoogle Scholar
  34. 34.
    Sabra MM, Tuttle RM. Recombinant human thyroid-stimulating hormone to stimulate 131-I uptake for remnant ablation and adjuvant therapy. Endocr Pract. 2013;19(1):149–56.CrossRefPubMedGoogle Scholar
  35. 35.
    Sherman SI. The role of recombinant human thyrotropin for diagnostic monitoring of patients with differentiated thyroid cancer. Endocr Pract. 2013;19(1):157–61.CrossRefPubMedGoogle Scholar
  36. 36.
    Anderson BO, Gralow JR. Axillary vs sentinel lymph node dissection for invasive breast cancer. JAMA. 2011;305(22):2290. Author reply 2290–2291CrossRefPubMedGoogle Scholar
  37. 37.
    Krag D, Weaver D, Ashikaga T, Moffat F, Klimberg VS, Shriver C, Feldman S, Kusminsky R, Gadd M, Kuhn J, Harlow S, Beitsch P. The sentinel node in breast cancer—a multicenter validation study. N Engl J Med. 1998;339(14):941–6.CrossRefPubMedGoogle Scholar
  38. 38.
    Morton DL, Thompson JF, Cochran AJ, Mozzillo N, Elashoff R, Essner R, Nieweg OE, Roses DF, Hoekstra HJ, Karakousis CP, Reintgen DS, Coventry BJ, Glass EC, Wang HJ, MSLT Group. Sentinel-node biopsy or nodal observation in melanoma. N Engl J Med. 2006;355(13):1307–17.CrossRefPubMedGoogle Scholar
  39. 39.
    Kloos RT, Eng C, Evans DB, Francis GL, Gagel RF, Gharib H, Moley JF, Pacini F, Ringel MD, Schlumberger M, Wells Jr SA. Medullary thyroid cancer: management guidelines of the American Thyroid Association. Thyroid. 2009;19(6):565–612.CrossRefPubMedGoogle Scholar
  40. 40.
    Kouvaraki MA, Shapiro SE, Fornage BD, Edeiken-Monro BS, Sherman SI, Vassilopoulou-Sellin R, Lee JE, Evans DB. Role of preoperative ultrasonography in the surgical management of patients with thyroid cancer. Surgery. 2003;134(6):946–54. Discussion 954–945CrossRefPubMedGoogle Scholar
  41. 41.
    Moley J, Dilley W, DeBenedetti M. Improved results of cervical reoperation for medullary thyroid carcinoma. Ann Surg. 1997;225:734–43.CrossRefPubMedPubMedCentralGoogle Scholar
  42. 42.
    Skinner MA, Moley JA, Dilley WG, Owzar K, Debenedetti MK, Wells Jr SA. Prophylactic thyroidectomy in multiple endocrine neoplasia type 2A. N Engl J Med. 2005;353(11):1105–13.Google Scholar
  43. 43.
    Olson JA, DeBenedetti MK, Baumann DS, Wells SA. Parathyroid autotransplantation during thyroidectomy. Results of long-term follow-up. Ann Surg. 1996;223(5):472–8. Discussion 478–480CrossRefPubMedPubMedCentralGoogle Scholar
  44. 44.
    Fialkowski E, DeBenedetti M, Moley J. Long-term outcome of reoperations for medullary thyroid carcinoma. World J Surg. 2008;32(5):754–65.CrossRefPubMedGoogle Scholar
  45. 45.
    Moley JF, Fialkowski EA. Evidence-based approach to the management of sporadic medullary thyroid carcinoma. World J Surg. 2007;31(5):946–56.CrossRefPubMedGoogle Scholar
  46. 46.
    Carling T, Long III WD, Udelsman R. Controversy surrounding the role for routine central lymph node dissection for differentiated thyroid cancer. Curr Opin Oncol. 2010;22(1):30–4.CrossRefPubMedGoogle Scholar
  47. 47.
    Giordano D, Valcavi R, Thompson GB, Pedroni C, Renna L, Gradoni P, Barbieri V. Complications of central neck dissection in patients with papillary thyroid carcinoma: results of a study on 1087 patients and review of the literature. Thyroid. 2012;22(9):911–7.CrossRefPubMedGoogle Scholar
  48. 48.
    Lang BH, Tang AH, Wong KP, Shek TW, Wan KY, Lo CY. Significance of size of lymph node metastasis on postsurgical stimulated thyroglobulin levels after prophylactic unilateral central neck dissection in papillary thyroid carcinoma. Ann Surg Oncol. 2012;19(11):3472–8.CrossRefPubMedPubMedCentralGoogle Scholar
  49. 49.
    Lombardi CP, Raffaelli M, De Crea C, Sessa L, Rampulla V, Bellantone R. Video-assisted versus conventional total thyroidectomy and central compartment neck dissection for papillary thyroid carcinoma. World J Surg. 2012;36(6):1225–30.CrossRefPubMedGoogle Scholar
  50. 50.
    Roh JL, Park JY, Park CI. Prevention of postoperative hypocalcemia with routine oral calcium and vitamin D supplements in patients with differentiated papillary thyroid carcinoma undergoing total thyroidectomy plus central neck dissection. Cancer. 2009;115(2):251–8.CrossRefPubMedGoogle Scholar
  51. 51.
    Sousa AA, Salles J, Soares J, Mpraes G, Carvalho J, Savassi-Rocha PR. Predictor factors for post-thyroidectomy hypocalcemia. RevColBrasCir. 2012;39(6):476–82.Google Scholar
  52. 52.
    Abboud B, Sleilaty G, Tannoury J, Daher R, Abadjian G, Ghorra C. Cervical neck dissection without drains in well-differentiated thyroid carcinoma. Am Surg. 2011;77(12):1624–8.PubMedGoogle Scholar
  53. 53.
    Boudourakis LD, Wang TS, Roman SA, Desai R, Sosa JA. Evolution of the surgeon-volume, patient-outcome relationship. Ann Surg. 2009;250(1):159–65.CrossRefPubMedGoogle Scholar
  54. 54.
    Sosa JA, Bowman HM, Tielsch JM, Powe NR, Gordon TA, Udelsman R. The importance of surgeon experience for clinical and economic outcomes from thyroidectomy. Ann Surg. 1998;228(3):320–30.CrossRefPubMedPubMedCentralGoogle Scholar
  55. 55.
    Carty SE. Atlas of endocrine surgical techniques. Jaypee Brothers Medical Publishers; 2016.Google Scholar

Copyright information

© The Author(s) 2017

Authors and Affiliations

  1. 1.Section of Endocrine and Oncologic SurgeryDepartment of Surgery, Washington University School of MedicineSt. LouisUSA

Personalised recommendations